Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Carcinoma Neuroendocrine

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Carcinoma Neuroendocrine:

Pubmed Logo
Solitary fibrous tumor of the pancreas.
A 67-year-old woman was found to have an incidental pancreatic mass on...
13th November, 2009
Department of Pathology, University Health Network/University of Toronto, Ann Diagn Pathol. 2009 Oct;13(5):339-43. Epub 2009 Apr 1.
DOI Direct Link
Primary extra-ampullary duodenal neuroendocrine carcinoma in an adult male.
A primary extra-ampullary duodenal neuroendocrine carcinoma was found in a...
13th November, 2009
Department of Surgery, St George's Hospital, Grant Medical College and Sir Dig Endosc. 2009 Jul;21(3):185-7.
DOI Direct Link
Three synchronous tumours identified by FDG-PET/CT.
A 67-year-old woman was found to have an incidental pancreatic mass on...
5th November, 2009
Liverpool Hospital, Sydney, NSW. Med J Aust. 2009 Sep 7;191(5):275.
Magnetic resonance imaging of cystic and endocrine pancreatic neoplasms.
This article describes the appearance of miscellaneous cystic and...
29th October, 2009
Department of Radiology, University of North Carolina, Chapel Hill, NC, Top Magn Reson Imaging. 2009 Feb;20(1):11-8.
DOI Direct Link
Mixed ovarian large cell neuroendocrine carcinoma, mucinous adenocarcinoma, and teratoma: a report of two cases and review of the literature.
Large cell neuroendocrine carcinoma of the ovary is a rare recently...
29th October, 2009
Department of Pathology, Centre de recherche clinique et evaluative en Pathol Res Pract. 2009;205(9):657-61. Epub 2009 Jul 3.
DOI Direct Link

View more research publications.

Press Releases About Carcinoma Neuroendocrine:

BioPortfolio Logo
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting 17th November, 2009 Oncolytics Biotech Inc.
CALGARY, Nov. 17 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase I/II U.K.
Oncolytics Biotech(R) Inc. Collaborators to Present Updated Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting 16th November, 2009 Oncolytics Biotech Inc.
CALGARY, Nov. 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced that a poster presentation covering updated
Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting 29th October, 2009 Onyx Pharmaceuticals, Inc.
-- Late Breaker #9 First-in-men Demonstration of Sorafenib Plus TACE for the Treatment of Advanced Hepatocellular Carcinoma (SOCRATES trial) -- Dr. Andreas Erhardt, Klinik fur
Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma 19th October, 2009 Jennerex, Inc.
SAN FRANCISCO, Oct. 19 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted
AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on Perifosine (KRX-0401) for the Treatment of Advanced Metastatic Renal Cell Carcinoma at 8th International Kidney Cancer Symposium in Chicago 29th September, 2009 AETERNA ZENTARIS INC.
Perifosine Continues to Demonstrate Impressive Efficacy, Safety and Tolerability in Metastatic Renal Cell Carcinoma Patients who Progressed after Failing Treatment with both a VEGF

Carcinoma Neuroendocrine Patents:

USPTO Logo
US Patent No.Title
6369210 22012, human carboxypeptidase
6664089 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor
6664098 Differentiation inhibitory agent
6673564 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
6723533 26934, a novel cytidine deaminase-like molecule and uses thereof

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Carcinoma Neuroendocrine scientists - we have details of around 92 individuals working on Carcinoma Neuroendocrine .


This page has been viewed 414 times
Recent Search Terms used to find this page: afinitor neuroendocrine carcinoma | carcinom neuroendocrin | carcinom neuroendocrin | carcinom neuroendocrin | carcinom neuroendocrin | carcinom neuroendocrin | neuroendocrine lung carcinoma wiki | carcinom logo | neuroendocrine cancer | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Carcinoma Neuroendocrine across BioPortfolio, or for Carcinoma Neuroendocrine Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.